Search

287 Result(s)
Sort by

Real stories, real impact: fighting rabies

Real stories, real impact: fighting rabies

The danger of rabies is often overlooked. The need for action, unseen. Learn how we can eliminate rabies through leveraging education and dog vaccinations.
Retinal health

Retinal health

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in Retinal Health.
Zactran®

Zactran®

Depending on species indication (and country of registration), the product is for the treatment and metaphylaxis control of respiratory disease in cattle caused by key bacteria (Mannheimia, Pasteurella, Histophilus and Mycoplasma) and footrot disease
Harold and Dorothy – Full Story

Harold and Dorothy – Full Story

T2D and CVD animation the full story – learn about the relationship between type 2 diabetes and cardiovascular disease
Our Curiosity Never Stops

Our Curiosity Never Stops

Dr. Cornelia Dorner-Ciossek shares her thoughts on the future of brain disease research.
Harold Heart and Dorothy Diabetes

Harold Heart and Dorothy Diabetes

People with type 2 diabetes are up to four times more likely to develop cardiovascular disease than people without diabetes.
equine asthma

equine asthma

Fighting Equine Asthma is a crucial step to improving the well-being of many horses worldwide. The right treatment can make a world of difference.
Vetera

Vetera

For vaccination of healthy horses as an aid in the prevention of diseases caused by the included antigens (US and Canada only).
NexGard Spectra

NexGard Spectra

Prevents heartworm disease and treats and controls hookworm, roundworm, whipworm, and lungworm infestations in dogs and puppies.
Our-position

Our-position

Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
Win Fight Against Cancer

Win Fight Against Cancer

At Boehringer Ingelheim we are giving patients new hope. We are collaborating with the oncology community on a shared journey to deliver leading science.
GlyT1 Phase II results

GlyT1 Phase II results

Boehringer Ingelheim refocuses Gly-T1 inhibition brain research on schizophrenia
Prascend

Prascend

Symptomatic treatment of clinical signs associated with pituitary pars intermedia dysfunction (PPID; also known as equine Cushing’s disease).